September 22, 2019

John M. Covert

Mr. Covert is a director in the Biotechnology/Chemical Group.  His practice is focused in technologies that involve organic chemistry, such as pharmaceuticals, coatings, fuels, lubricants and pesticides.  He is experienced in a number of interdisciplinary areas, including computer-aided drug design, combinatorial chemistry and medical devices.  He provides counseling with regard to patent portfolio strategy and management with issues that range from licensing, collaborations and technology acquisitions, to patent validity, infringement and design around strategies.

Mr. Covert has performed intellectual property due diligence investigations on behalf of clients seeking to acquire early and late stage pharmaceutical product candidates, drug design platforms, technology for controlling biological reactions, and assisted in all aspects of technology transfer in the pharmaceutical and biotechnology fields.

Articles in the National Law Review database by John M. Covert

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, September 24, 2019
Thursday, September 26, 2019
Thursday, October 17, 2019
Wednesday, October 23, 2019
Wednesday, November 6, 2019
Wednesday, November 13, 2019
Wednesday, December 11, 2019